Mc Ilrath & Eck, LLC Merck & Co., Inc. Transaction History

Mc Ilrath & Eck, LLC

$494 Million
Q2 2024

A detailed history of Mc Ilrath & Eck, LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Mc Ilrath & Eck, LLC holds 4,905 shares of MRK stock, worth $472,400. This represents 0.12% of its overall portfolio holdings.

Number of Shares

4,905

Previous 4,473 9.66%

Holding current value

$472,400

Previous $590,000 2.88%

% of portfolio

0.12%

Previous 0.12%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$123.8 - $132.96 $53,481 - $57,438	432 Added 9.66%	4,905 $607,000
Q1 2024 May 10, 2024	BUY	$113.24 - $131.95 $40,086 - $46,710	354 Added 8.59%	4,473 $590,000
Q4 2023 Feb 05, 2024	BUY	$100.18 - $109.02 $9,416 - $10,247	94 Added 2.34%	4,119 $449,000
Q3 2023 Nov 15, 2023	BUY	$102.95 - $114.33 $28,517 - $31,669	277 Added 7.39%	4,025 $414,000
Q2 2023 Aug 07, 2023	SELL	$108.61 - $118.38 $28,781 - $31,370	-265 Reduced 6.6%	3,748 $432,000
Q1 2023 May 08, 2023	BUY	$102.94 - $114.86 $21,926 - $24,465	213 Added 5.61%	4,013 $426,000
Q4 2022 Feb 14, 2023	SELL	$87.44 - $112.11 $48,354 - $61,996	-553 Reduced 12.7%	3,800 $421,000
Q3 2022 Oct 18, 2022	BUY	$84.53 - $94.96 $38,630 - $43,396	457 Added 11.73%	4,353 $375,000
Q2 2022 Jul 29, 2022	BUY	$83.49 - $94.64 $7,013 - $7,949	84 Added 2.2%	3,896 $355,000
Q1 2022 May 11, 2022	BUY	$73.51 - $82.4 $5,733 - $6,427	78 Added 2.09%	3,812 $313,000
Q4 2021 Feb 08, 2022	BUY	$72.28 - $90.54 $14,817 - $18,560	205 Added 5.81%	3,734 $286,000
Q2 2021 Aug 09, 2021	BUY	$70.31 - $77.77 $22,217 - $24,575	316 Added 9.84%	3,529 $274,000
Q1 2021 May 12, 2021	BUY	$68.86 - $81.11 $64,177 - $75,594	932 Added 40.86%	3,213 $248,000
Q4 2020 Feb 05, 2021	SELL	$71.77 - $79.65 $5,310 - $5,894	-74 Reduced 3.14%	2,281 $187,000
Q3 2020 Nov 13, 2020	BUY	$73.18 - $82.95 $6,000 - $6,801	82 Added 3.61%	2,355 $195,000
Q2 2020 Aug 04, 2020	BUY	$70.42 - $80.13 $32,956 - $37,500	468 Added 25.93%	2,273 $176,000
Q1 2020 May 14, 2020	BUY	$63.36 - $87.82 $1,267 - $1,756	20 Added 1.12%	1,805 $139,000
Q4 2019 Feb 11, 2020	BUY	$77.58 - $87.54 $53,607 - $60,490	691 Added 63.16%	1,785 $162,000
Q1 2019 May 07, 2019	BUY	$69.58 - $79.36 $7,862 - $8,967	113 Added 11.52%	1,094 $91,000
Q4 2018 May 07, 2019	BUY	$65.24 - $75.71 $8,546 - $9,918	131 Added 15.41%	981 $75,000
Q3 2018 Nov 13, 2018	BUY	$57.69 - $67.84 $3,865 - $4,545	67 Added 8.56%	850 $60,000
Q2 2018 Aug 07, 2018	SELL	$50.83 - $59.72 $23,890 - $28,068	-470 Reduced 37.51%	783 $48,000
Q1 2018 May 22, 2018	SELL	$50.96 - $59.23 $76,898 - $89,378	-1,509 Reduced 54.63%	1,253 $68,000
Q4 2017 Mar 19, 2018	BUY	$51.62 - $61.64 $142,574 - $170,249	2,762	2,762 $155,000

Others Institutions Holding MRK

# of Institutions

3,821

Shares Held

1.88B

Call Options Held

15.6M

Put Options Held

13.7M

View Full List

About Merck & Co., Inc.

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $244B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

More about MRK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Mc Ilrath & Eck, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Mc Ilrath & Eck, LLC with notifications on news.

Account